Sanofi
์๊ฐ์ด์ก
$100.5B
๊ธ๋ก๋ฒ ์์
#164
์ญ๋ ์ต๊ณ ์น
$109.9B
2024-12-31
์ด ์ฑ์ฅ๋ฅ
+0%
2026๋ ์ดํ
Market Cap Context
- Larger than 55% of the 367 companies we track (globally).
- Equivalent to 3.0% of France's GDP (2025 data).
- Just above: #163 AXA SA ($100.6B)
- Just below: #165 ํํ ์ปจ์คํด์ ์๋น์ค(TCS) ($99.0B)
- Best year: 2012 (+32%). Worst year: 2002 (-30%).
Sanofi Financial Breakdown (FY 2025)
Source: Yahoo Finance โ SAN.PA annual filings (2025) (converted from EUR at 0.93) โ$50.2B revenue ยท $10.3B operating income ยท $8.4B net income
- โOperating margin: 20.5% on $50.2B in revenue.
- โR&D is 16.8% of revenue ($8.4B).
- โNet income margin: 16.7% โ $8.4B in profit.
- โFree cash flow: $7.8B (15.4% of revenue).
Cost / Operating Expenses
Total operating expenses $39.9B
Total
$33.5B
Capital Expenditures
$3.8B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$7.8B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Sanofi ์๊ฐ
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthรฉlabo in 1999 to form Sanofi-Synthรฉlabo. In 2004, Sanofi-Synthรฉlabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi ์๊ฐ์ด์ก ์ถ์ด (2026โ2026)
Sanofi vs Sector Peers by Market Cap
Sanofi ๋น๊ต
์์ ์ถ์ด
| ์ฐ๋ | ์๊ฐ์ด์ก | ์์ | ์ ๋ ๋๋น ๋ณํ |
|---|---|---|---|
| 2026 | $100.5B | #164(โ16) | -0.8% |
| 2025 | $101.3B | #148(โ25) | -7.9% |
| 2024 | $109.9B | #123(โ12) | +8.8% |
| 2023 | $101.1B | #111(โ14) | +3.6% |
| 2022 | $97.5B | #97(โ12) | +5.5% |
| 2021 | $92.4B | #109(โ1) | +16.9% |
| 2020 | $79.1B | #108(โ30) | -9.0% |
| 2019 | $86.8B | #78(โ8) | +23.4% |
| 2018 | $70.3B | #70(โ16) | +10.4% |
| 2017 | $63.7B | #86(โ29) | -3.5% |
| 2016 | $66.0B | #57(โ1) | +2.0% |
| 2015 | $64.7B | #56(โ3) | +7.2% |
| 2014 | $60.3B | #59(โ6) | +1.8% |
| 2013 | $59.3B | #53(โ12) | +11.6% |
| 2012 | $53.1B | #41(โ8) | +31.8% |
| 2011 | $40.3B | #49(โ16) | +24.1% |
| 2010 | $32.5B | #65(โ14) | -8.7% |
| 2009 | $35.6B | #51(โ5) | +27.9% |
| 2008 | $27.8B | #46(โ10) | -24.7% |
| 2007 | $36.9B | #56(โ15) | -7.6% |
| 2006 | $39.9B | #41(โ10) | -3.0% |
| 2005 | $41.2B | #31(โ3) | +28.5% |
| 2004 | $32.0B | #34 | +1.5% |
| 2003 | $31.6B | #34(โ6) | +4.1% |
| 2002 | $30.3B | #28(โ6) | -29.8% |
| 2001 | $43.2B | #22(โ18) | +18.8% |
| 2000 | $36.3B | #40 |
๊ธฐํ ํฌ์ค์ผ์ด ๊ธฐ์
์์ฃผ ๋ฌป๋ ์ง๋ฌธ
What is Sanofi's market cap?
Sanofi (SAN.PA) has a market capitalization of $100.5B, making it the #164 largest company in the world by market cap.
What was Sanofi's highest market cap?
Sanofi's all-time high market cap was $109.9B, reached in 2024-12-31. Its highest rank was #123 in 2024.
What sector is Sanofi in?
Sanofi is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in France.
How has Sanofi's market cap changed over time?
Sanofi has been tracked since 2026. Its market cap has grown by 0% from $100.5B in 2026 to $100.5B today.